TY - JOUR
AU - Cordeiro, Ana Sara
AU - Patil-Sen, Yogita
AU - Shivkumar, Maitreyi
AU - Patel, Ronak
AU - Khedr, Abdulwahhab
AU - Elsawy, Mohamed A.
PY - 2021
DA - December
TI - Nanovaccine delivery approaches and advanced delivery systems for the prevention of viral infections: from development to clinical application
JO - Pharmaceutics
VL - 13
IS - 12
DO - https://doi.org/10.3390/pharmaceutics13122091
AB - Viral infections causing pandemics and chronic diseases are the main culprits implicated in devastating global clinical and socioeconomic impacts, as clearly manifested during the current COVID-19 pandemic. Immunoprophylaxis via mass immunisation with vaccines has been shown to be an efficient strategy to control such viral infections, with the successful and recently accelerated development of different types of vaccines, thanks to the advanced biotechnological techniques involved in the upstream and downstream processing of these products. However, there is still much work to be done for the improvement of efficacy and safety when it comes to the choice of delivery systems, formulations, dosage form and route of administration, which are not only crucial for immunisation effectiveness, but also for vaccine stability, dose frequency, patient convenience and logistics for mass immunisation. In this review, we discuss the main vaccine delivery systems and associated challenges, as well as the recent success in developing nanomaterials-based and advanced delivery systems to tackle these challenges. Manufacturing and regulatory requirements for the development of these systems for successful clinical and marketing authorisation were also considered. Here, we comprehensively review nanovaccines from development to clinical application, which will be relevant to vaccine developers, regulators, and clinicians.
PB - MDPI
UR - https://strathprints.strath.ac.uk/92831/
KW - Coronavirus (COVID-19)
KW - Immunisation and screening
ER